Mutation agnostic diagnosis of clonal hematopoiesis of indeterminate potential (CHIP) using fluctuating methylation clocks

Mutation agnostic diagnosis of clonal hematopoiesis of indeterminate potential (CHIP) using fluctuating methylation clocks

Bibliographic Details
Main Authors:	Schenck, RO, Jakobsen, NA, Turati, V, Shibata, D, Vyas, P, Leedham, S, Anderson, ARA
Format:	Conference item
Language:	English
Published:	American Association for Cancer Research 2022

Similar Items

Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
by: Nagendra Boopathy Senguttuvan, et al.
Published: (2021-07-01)

Clonal hematopoiesis of indeterminate potential and heart failure
by: E. A. Lyasnikova, et al.
Published: (2024-12-01)

Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease
by: M d Mesbah Uddin, et al.
Published: (2022-09-01)

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
by: Marie-France Gagnon, et al.
Published: (2022-07-01)

Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high morbidity
by: Jasper David Feldkamp, et al.
Published: (2022-03-01)

Clonal hematopoiesis of indeterminate potential (CHIP): A potential contributor to atherlosclerotic cardio/cerebro-vascular diseases?
by: Fei Li, et al.
Published: (2018-06-01)

Copy number alterations detected as clonal hematopoiesis of indeterminate potential
by: Koichi Takahashi, et al.
Published: (2017-06-01)

Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent Studies
by: Adrian Schmidt
Published: (2021-10-01)

Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
by: Gregor Hoermann
Published: (2022-07-01)

Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies
by: Luka Komic, et al.
Published: (2023-06-01)

Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients
by: Aparna C. Swaminathan, et al.
Published: (2023-10-01)

Increased frequency of clonal hematopoiesis of indeterminate potential in Bloom syndrome probands and carriers
by: Isabella Lin, et al.
Published: (2024-07-01)

Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood
by: Art Schuermans, et al.
Published: (2023-07-01)

Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential
by: Anna Maria Cacic, et al.
Published: (2023-12-01)

Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD
by: Stefan Kuhnert, et al.
Published: (2022-07-01)

Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers
by: Francesco Vieceli Dalla Sega, et al.
Published: (2022-11-01)

Clonal hematopoiesis of indeterminate potential: clinical relevance of an incidental finding in liquid profiling
by: Hoermann Gregor
Published: (2022-08-01)

Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19
by: Judith Schenz, et al.
Published: (2022-10-01)

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV
by: Alexander G. Bick, et al.
Published: (2022-01-01)

P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19.
by: Federico Mario Aletti, et al.
Published: (2023-08-01)

Clonal hematopoiesis of indeterminate potential and its impact on patient trajectories after stem cell transplantation
by: Park, D, et al.
Published: (2019)

Clonal hematopoiesis of indeterminate potential and the risk of pulmonary embolism: an observational studyResearch in context
by: Qianwei Liu, et al.
Published: (2024-08-01)

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
by: Maurits A. Sikking, et al.
Published: (2023-08-01)

Healthy Lifestyle and Clonal Hematopoiesis of Indeterminate Potential: Results From the Women's Health Initiative
by: Bernhard Haring, et al.
Published: (2021-03-01)

JAK2V617F-positive clonal hematopoiesis of indeterminate potential in pregnant women
by: I. A. Olkhovskiy, et al.
Published: (2019-09-01)

P1642: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL ARE ASSOCIATED WITH INCREASED NETOSIS IN PATIENTS WITH CARDIOVASCULAR EVENTS
by: Severine Marti, et al.
Published: (2023-08-01)

Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV
by: Alexander G. Bick, et al.
Published: (2022-07-01)

Considering clonal hematopoiesis of indeterminate potential in space radiation risk analysis for hematologic cancers and cardiovascular disease
by: Charles M. Werneth, et al.
Published: (2024-06-01)

Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Risk in Patients with Chronic Kidney Disease without Previous Cardiac Pathology
by: Maria Kislikova, et al.
Published: (2023-08-01)

1492 Clonal hematopoiesis of indeterminate potential alters solid tumor microenvironment and outcomes in triple negative breast cancer
by: Sarah C Reed, et al.
Published: (2023-11-01)

Evolution of clonal hematopoiesis
by: Isabelle A. van Zeventer, et al.
Published: (2023-10-01)

Clonal hematopoiesis of indeterminate potential is a risk factor of gastric cancer: A Prospective Cohort in UK Biobank study
by: Zhihui Xi, et al.
Published: (2025-02-01)

Relationship between clonal hematopoiesis of indeterminate potential and severity of coronary stenosis in coronary heart disease patients with renal insufficiency
by: ZHONG Jialin, et al.
Published: (2024-12-01)

Clonal Hematopoiesis of Indeterminate Potential Is Associated with Current Smoking Status and History of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease
by: Jung-Kyu Lee, et al.
Published: (2024-07-01)

P1370: EFFECTS OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL FROM HEALTHY DONORS ON RECIPIENTS AFTER TRANSPLANTATION AND RELATED RESEARCH
by: B. Shen, et al.
Published: (2022-06-01)

CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease
by: Angela Todorovski, et al.
Published: (2025-01-01)

Clonal hematopoiesis of indeterminate potential, health indicators, and risk of cardiovascular diseases among patients with diabetes: a prospective cohort study
by: Ying Sun, et al.
Published: (2025-02-01)

The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases
by: Isaac M. Emon, et al.
Published: (2023-10-01)

Genetic Predisposition to Clonal Hematopoiesis
by: Pedro M. Quiros, et al.
Published: (2023-09-01)

Discovering the drivers of clonal hematopoiesis
by: Oriol Pich, et al.
Published: (2022-07-01)